Huons Co Ltd banner
H

Huons Co Ltd
KOSDAQ:243070

Watchlist Manager
Huons Co Ltd
KOSDAQ:243070
Watchlist
Price: 26 800 KRW -0.19% Market Closed
Market Cap: ₩321.1B

Huons Co Ltd
Net Change in Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Huons Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
H
Huons Co Ltd
KOSDAQ:243070
Net Change in Cash
₩8.3B
CAGR 3-Years
-30%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Net Change in Cash
₩42.1B
CAGR 3-Years
2%
CAGR 5-Years
-12%
CAGR 10-Years
-4%
SK Biopharmaceuticals Co Ltd
KRX:326030
Net Change in Cash
-₩15B
CAGR 3-Years
50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Net Change in Cash
-₩84B
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Net Change in Cash
-₩9.6B
CAGR 3-Years
29%
CAGR 5-Years
-48%
CAGR 10-Years
N/A
C
Caregen Co Ltd
KOSDAQ:214370
Net Change in Cash
₩3.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Huons Co Ltd
Glance View

Market Cap
321.1B KRW
Industry
Pharmaceuticals

Huons Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2016-06-03.

Intrinsic Value
32 806.51 KRW
Undervaluation 18%
Intrinsic Value
Price ₩26 800
H

See Also

What is Huons Co Ltd's Net Change in Cash?
Net Change in Cash
8.3B KRW

Based on the financial report for Sep 30, 2025, Huons Co Ltd's Net Change in Cash amounts to 8.3B KRW.

What is Huons Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
40%

The average annual Net Change in Cash growth rates for Huons Co Ltd have been -30% over the past three years , 40% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett